|

AKERO THERAPEUTICS INC (AKRO)

US00973Y1082 - Common Stock

16.74  +0.08 (+0.48%)

After market: 16.461 -0.28 (-1.67%)

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
136.42M115.16M100.89M80.15M45.65M
Research and Development
106.73M85.28M81.76M64.92M37.05M
Selling, General, and Administrative Expenses
29.69M29.87M19.13M15.24M8.61M
Operating Income
-136.42M-115.16M-100.89M-80.15M-45.65M
Interest Income/Expense
12.93M-740.00K110.00K950.00K0.00
Other Income/Expense
N/A3.86MN/AN/A1.90M
Income Before Taxes
-119.63M-112.03M-100.78M-79.21M-43.76M
Income Tax
N/A0.000.000.00N/A
Net Income
-119.63M-112.03M-100.78M-79.21M-43.76M
EBITDA
-136.38M-115.12M-100.85M-80.13MN/A
 
Per Share Data
EPS Diluted Total Ops
-2.35-2.87-2.89-2.52-2.90
Non GAAP EPS
-2.35-2.92-2.89-2.48N/A
 
Statistics

All data in USD

Charts